[Event Report] Health Policy Summit 2017
Health and Global Policy Institute held the Health Policy Summit 2017 on February 18, 2017 within the city of Tokyo.
This summit gathered many top leaders in the field of health policy, including medical specialists, and members of academia, the Government, corporations, and the media, in order to tackle three main topics: sustainability in health care; global health; and the future of health care.
From these three perspectives,lively discussions on future visions and urgent issues were carried out.
Minister of Health, Labour and Welfare
Keynote address by Mr. Yasuhisa Shiozaki of Minister of Health, Labour and Welfare provided on future prospects of social security systems to stablilize stable growth in Japan, an ultra-aging society ranking among the top countries in the world in terms of life expectancy. He gave his thoughts on healthcare plans and caregiving services with effective use of innovative technologies, such as big data and AI, from the perspective of patients, citizens, and users based on guidelines established two years ago by MHLW titled Japan Vision: Health Care 2035”.
Session 1 Sustainability of Japanese Health System
In the midst of constrained national financial resources, effective use of limited resources and sustainable social security system should be maintained. Striking a balance between investing on high priced drugs, health ICT, and innovation and maintaining sustainable financial resources has become a dilemma not only in Japan, but a problem experienced by many developed countries. Discussions among various stakeholders covered not only urgent issues such as simultaneous revision of treatment reimbursement and caregiving remuneration in 2018, but also involve mid to long term prospect and state of the healthcare field in general.
Executive Director, Japan Federation of Cancer Patient Groups
Director General of Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW)
President, Japan Medical Association; President-Elect, World Medical Association
Board Member, Health and Global Policy Institute
Session 2 Japan’s Commitment to Global Health Policy
In 2016, Japan hosted G7 Ise-Shima Summit, and G7 Health Ministers Meeting in May and September respectively. The outcomes from each meeting strongly emphasized the critical role of global health and Japan’s commitment. In this session, we had a reflective discussion on the 2016 initiatives and prospects for the future of global health with key opinion leaders. As topics in the field of health policy and global health tend to involve issues that are both domestic and global in nature such as infectious disease, AMR, R&D, and globalized pharmaceutical industry. The role of each key stakeholder and ideal partnership mechanism for ongoing global health agendas were discussed.
President Johnson & Johnson K.K. and Medical Company
Project Professor, Global Research Institute, Keio University
Assistant Minister for Global Health and Health Industry Strategy, Ministry of Health, Labour and Welfare (MHLW)
CEO and Executive Director, Global Health Innovative Technology Fund
Session 3 The Future of Health with AI and Big Data
Human health has been redefined based on new evidences regarding the development of diagnostic tools via artificial intelligence and health data analysis through the active use of accumulative data based on health ICT. The creation of new technology and innovation is about finding ways to improve the already existing health system, making discoveries in current issues, tending to public concerns, and opening up new opportunities. Multi-stakeholders in industry, government, and academia proposed useful examples and topics from their respective fields along with discuss the future of healthcare based on innovation. In this session, HGPI’s public opinion survey on health ICT and remote health was presented.
Director, Healthcare Industries Division, Commerce and Information Policy Bureau, Ministry of Economy, Trade and Industry
Associate Director, Institute for Health Economics and Policy
Professor, Department of Health Informatics; Vice Dean, Graduate School of Medicine; Dean, School of Public Health, Kyoto University.
Board Member, Health and Global Policy Institute
CEO, MICIN; Fellow, Health and Global Policy Institute
Dr. Kiyoshi Kurokawa, Chairman of HGPI, showed gratitude to all participants and presented the future vision of the world.
Co-hosted by National Graduate Institute for Policy Studies (GRIPS), Global Health Innovation Policy Program (GHIPP)
Special sponsorship from Miraca Holdings
Sponsorship from Global Health Innovative Technology Fund (GHIT Fund)
Supported by Ministry of Health, Labour and Welfare (MHLW); Ministry of Foreign Affairs (MOFA)
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
- [Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (AMR Alliance Japan, December 22, 2021)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] The Future of Dementia Policy 2022: Deepening Dementia Policies Centered on People Living with Dementia and their Families to Lead Global Society (July 13, 2022)
- [Announcement] HGPI Declares the Ministry of the Environment-led ‘Deco-Katsu Declaration’ and Participation in the ‘Deco-Katsu’ Supporters (October 16, 2023)
[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
[Registration Open] (Webinar) HGPI Cooperation with Lancet Countdown 2023 Japan Presentation “Climate Change as a Children’s Health Issue: The Latest Lancet Report Sounds the Alarm for Health Commitments” (December 14, 2023)
[Event Report] The 1st Advisory Board Meeting for Patient and Public Involvement (PPI) Support Project “Necessary Steps for Promoting PPI in Policy Making” (October 3, 2023)
[Policy Recommendations] Coming Together to Protect and Foster: Promoting Innovative and Sustainable Planetary Health in the Asia-Pacific Region to Build Resilient Health Systems (November 29, 2023)
[Announcement] HGPI Endorsed “For the Health of People and Planet: Priorities for a Healthy COP28” (November 30, 2023)